The availability of SGLT2i has revolutionised the management of chronic kidney disease and diabetes.
Join us on Thursday, 20 July 2023 from 7:00 pm to 8:00 pm (AEST) as we explore the latest evidence of how this class of drugs protects the kidney and the evidence for best practice when managing people with diabetes.

Discussion points include:

• Why SGLT2i is the class of choice for protecting the kidney
• Early use of SGLT2i in the management of type 2 diabetes
• The ideal patient for starting SGLT2i
• Sick day management plans and other areas of discussion

Speakers

Click here to view the event flyer.
Click here to register for the webinar.

This webinar is registered for 1 CPD hour with the RACGP CPD Program and certificate of attendance available upon request.

For any further information please contact the ADS Secretariat via email to admin@diabetessociety.com.au